当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.
Nature Medicine ( IF 82.9 ) Pub Date : 2020-06-18 , DOI: 10.1038/s41591-020-0978-1
Priscilla K Brastianos 1 , Eudocia Quant Lee 2 , Justine V Cohen 1 , Sara M Tolaney 2 , Nancy U Lin 2 , Nancy Wang 1 , Ugonma Chukwueke 2 , Michael D White 1 , Naema Nayyar 1 , Albert Kim 1 , Christopher Alvarez-Breckenridge 1 , Ian Krop 2 , Maura Keeley Mahar 1 , Mia S Bertalan 1 , Brian Shaw 1 , Joana L Mora 1 , Nathaniel Goss 1 , Megha Subramanian 1 , Lakshmi Nayak 2 , Jorg Dietrich 1 , Deborah A Forst 1 , Brian V Nahed 1 , Tracy T Batchelor 1 , Helen A Shih 1 , Elizabeth R Gerstner 1 , Beverly Moy 1 , Donald Lawrence 1 , Anita Giobbie-Hurder 2 , Scott L Carter 2 , Kevin Oh 1 , Daniel P Cahill 1 , Ryan J Sullivan 1
Affiliation  

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

中文翻译:

出版商更正:pembrolizumab在软脑膜癌病患者中的单臂开放标签2期试验。

该文件的修订版已经发布,可以通过文件顶部的链接进行访问。
更新日期:2020-06-18
down
wechat
bug